Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_assertion type Assertion NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_head.
- NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_assertion description "[In this study, the human GBX2 cDNA was cloned and a quantitative reverse transcription-PCR method used to demonstrate that GBX2 mRNA expression is enhanced in approximately 70% of human prostate cancer tissues compared with normal human prostate tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_provenance.
- NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_assertion evidence source_evidence_literature NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_provenance.
- NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_assertion SIO_000772 10690529 NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_provenance.
- NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_assertion wasDerivedFrom befree-20140225 NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_provenance.
- NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_assertion wasGeneratedBy ECO_0000203 NP438294.RAyZ5A4x30duUUdqnxewVmKFPqWVD_DyE1b-e6oFoc_1I130_provenance.